Answers are grounded in this paper and cite their sources.
The modified Xiaoyao San (MXS) formula is an adjuvant drug recommended by the National Health Commission of China for the treatment of liver cancer, which has the effect of preventing postoperative recurrence and metastasis of hepatocellular carcinoma and prolonging patient survival. However, the molecular mechanisms underlying that remain unclear.
No takes yet. Share an insight, caveat, or question.
Mei et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: